Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 5;16(8):e0255732.
doi: 10.1371/journal.pone.0255732. eCollection 2021.

Acupuncture for glucose and lipid metabolic disorders of polycystic ovarian syndrome: A systematic review protocol

Yang Wu  1 , Tao Peng  1 , Yu Chen  2 , Li Huang  3 , Bisong He  1 , Shaobin Wei  3
Affiliations

Acupuncture for glucose and lipid metabolic disorders of polycystic ovarian syndrome: A systematic review protocol

Yang Wu et al. PLoS One. .

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common gynecological disease that is often accompanied by some metabolic abnormality such as insulin resistance and dyslipidemia. As a non-pharmacological therapy, acupuncture is widely used for the treatment of PCOS, but the effectiveness for insulin resistance and lipid metabolic disorder remains controversial.

Objectives: To assess the effectiveness and safety of acupuncture for insulin resistance and lipid metabolic disorder of women with PCOS.

Search methods: Eight databases will be searched from inception to June 2021, three clinical trial registration platforms will be searched for relevant trials.

Selection criteria: Randomized controlled trials (RCTs) of acupuncture therapy for insulin resistance and lipid metabolic of PCOS will be included.

Data collection and analysis: Study screening, data collection, and analysis will be performed by two or more reviewers independently. We will calculate mean difference (MD), standard mean difference (SMD) with 95% confidence intervals (CIs). Data synthesis will be performed with RevMan V.5.3 software and with Stata V.15.0 software when necessary.

Prospero registration number: CRD42020177846.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human reproduction (Oxford, England). 2004;19(1):41–7. doi: 10.1093/humrep/deh098 - DOI - PubMed
    1. Li R, Yu G, Yang D, Li S, Lu S, Wu X, et al. Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross-sectional study. BMC endocrine disorders. 2014;14:76. doi: 10.1186/1472-6823-14-76 - DOI - PMC - PubMed
    1. Ng NYH, Jiang G, Cheung LP, Zhang Y, Tam CHT, Luk AOY, et al. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study. PLoS medicine. 2019;16(10):e1002953. doi: 10.1371/journal.pmed.1002953 - DOI - PMC - PubMed
    1. Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030. doi: 10.1210/er.2011-1034 - DOI - PMC - PubMed
    1. Cibula D. Is insulin resistance an essential component of PCOS?: The influence of confounding factors. Human reproduction (Oxford, England). 2004;19(4):757–9. doi: 10.1093/humrep/deh137 - DOI - PubMed

Publication types